Threshold Pharmaceuticals (THLD) Reports In-Line Q3 Loss of 6c/Share
Get Alerts THLD Hot Sheet
Join SI Premium – FREE
Threshold Pharmaceuticals (NASDAQ: THLD) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $2.29 million.
For earnings history and earnings-related data on Threshold Pharmaceuticals (THLD) click here.
For earnings history and earnings-related data on Threshold Pharmaceuticals (THLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FreightCar America (RAIL) Misses Q4 EPS by 6c, provides guidance
- DLocal Limited (DLO) Misses Q4 EPS by 5c, offers outlook
- U.S. Steel (X) slightly down as Q1 guidance fails to meet expectations
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!